FierceBiotech 2026-01-06 Arrowhead takes aim at obesity market with early data on dual gene silencing assets
FierceBiotech 2026-01-06 Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
FierceBiotech 2026-01-06 Bright Minds shines with phase 2 win for anti-seizure serotonin receptor activator
FierceBiotech 2026-01-06 Boehringer continues kidney disease dealmaking run with $120M Variant Bio pact
FierceBiotech 2026-01-06 FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection
FierceBiotech 2026-01-06 UK biotech eyes $1B deal to enable eye gene therapy to be delivered in doctors' offices
FierceBiotech 2026-01-05 Zenas' stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit
FierceBiotech 2026-01-05 Abbott launches AI-based Libre Assist, its new in-app feature for meal planning
FierceBiotech 2026-01-05 Insilico, fresh off its Hong Kong IPO, pens potential $888M cancer R&D pact with Servier
FierceBiotech 2026-01-02 Cellular energy booster restores cognition in mice with advanced Alzheimer’s disease